Table 4 Cox Regression Analysis

African American (all other races)

<0.0001

2.00 (1.63–2.48)

<0.0001

3.41 (1.99–5.84)

4.87 (3.18–7.45)

Graft loss^B (Absent)

<0.0001

1.63 (1.25–2.12)

Cadaveric Donor (living donor)

0.027

2.14 (1.09–4.19)

Quartiles of Age (vs. >55 years)

<33

<0.0001

6.64 (4.59–9.61)

33–44

<0.0001

4.75 (3.31–6.79)

2.13 (1.34–3.37)

45–55

<0.0001

2.16 (1.47–3.17)

Diabetes at listing (vs. absent)

10.06 (7.60–13.30)

Excluded

0.0015

2.15 (1.34–3.46)

BMI <21.6 vs. >28.3 kg/m²

<0.0001

1.94 (1.44–2.62)

2.33 (1.09–5.00)

Recipient HCV Positive (Yes/No)

0.01

2.16 (1.20–3.89)

Year of Transplant

<0.0001

1.49 (1.33–1.67)

1.49 (1.25–1.78)

0.001

1.73 (1.17–2.56)

Pretransplant dialysis (Yes/No)

<0.0001

2.11 (1.42–3.12)

Cause of ESRD (vs. all others)

Diabetes

<0.0001

10.59 (8.52–13.18)

Excluded

Maintenance Medications

Tacrolimus (vs. Cyclosporine)

0.019

2.20 (1.13–4.24)

Interaction Terms

Tacrolimus*Cadaver Donor

0.02

2.27 (1.17–4.41)

Tacrolimus*Year of Transplant

0.03

0.70 (0.50–0.97)